ScholarX

Journal of Clinical Oncology

Journal Title

  • Journal of Clinical Oncology

ISSN

  • E 1527-7755 | P 0732-183X

Publisher

  • American Society of Clinical Oncology

Listed on(Coverage)

JCR 1997-2023
SJR 1999-2020;2022-2023
CiteScore 2011-2023
SCI 2010-2019
SCIE 2010-2024
CC 2016-2024
SCOPUS 2017-2024
MEDLINE 2016-2024
EMBASE 2016-2024

Active

  • Active

    based on the information

    • SCOPUS:2024-10

Country

  • USA

Aime & Scopes

  • JCO publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. Its readership comprises practicing clinical oncologists, researchers, students, individuals in training, and allied health professionals throughout the world. Members of the American Society of Clinical Oncology as well as nonmember subscribers and patrons of medical libraries globally utilize the groundbreaking research published in each issue of JCO.

Homepage

Article List

141 - 160 out of 1,009 results.

SCIESCOPUS
Phase 1b/2 study of GX-I7 plus pembrolizumab in patients with refractory or recurrent (R/R) metastatic triple-negative breast cancer (mTNBC): The KEYNOTE-899 Study.

Sohn, J[Sohn, Joohyuk]; Kim, GM[Kim, Gun Min]; Lee, KS[Lee, Keun Seok]; Kim, SB[Kim, Sung-Bae]; Kim, JH[Kim, Jee Hung]; Ahn, HK[Ahn, Hee Kyung]; Lee, J[Lee, Jieun]; Park, KH[Park, Kyong Hwa]; Kim, JH[Kim, Jee Hyun]; Lee, KE[Lee, Kyoung Eun], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Open-label, randomized, multicenter, phase 3 study evaluating trastuzumab deruxtecan (T-DXd) as first-line treatment in patients with unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 19 or 20 mutations (DESTINY-Lung04).

Li, BT[Li, Bob T.]; Ahn, MJ[Ahn, Myung-Ju]; Goto, K[Goto, Koichi]; Mazieres, J[Mazieres, Julien]; Padda, SK[Padda, Sukhmani Kaur]; William, WN[William, Nassib William]; Wu, YL[Wu, Yi-Long]; Dearden, S[Dearden, Simon]; Ragone, A[Ragone, Alejandra]; Viglianti, N[Viglianti, Natasha], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Pralsetinib in patients (pts) with advanced or metastatic RET-altered thyroid cancer (TC): Updated data from the ARROW trial.

Mansfield, AS[Mansfield, Aaron Scott]; Subbiah, V[Subbiah, Vivek]; Schuler, MH[Schuler, Martin H.]; Zhu, VW[Zhu, Viola Weijia]; Hadoux, J[Hadoux, Julien]; Brose, MS[Brose, Marcia S.]; Curigliano, G[Curigliano, Giuseppe]; Wirth, LJ[Wirth, Lori J.]; Garralda, E[Garralda, Elena]; Adkins, D[Adkins, Douglas], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Tumor-infiltrating lymphocyte enrichment predicted by CT radiomic analysis is associated with clinical outcomes of immune checkpoint inhibitor in non-small cell lung cancer

Park, C[Park, Changhee]; Jeong, DY[Jeong, Dong Young]; Choi, Y[Choi, Yeonu]; Oh, YJ[Oh, You Jin]; Kim, J[Kim, Jonghoon]; Pereira, S[Pereira, Sergio]; Paeng, K[Paeng, Kyunghyun]; Ock, CY[Ock, Chan-Young]; Lee, SH[Lee, Se-Hoon]; Lee, HY[Lee, Ho Yun]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Phase 1b study of vactosertib in combination with oxaliplatin with 5FU/LV (FOLFOX) in patients with metastatic pancreatic cancer who have failed first-line gemcitabine/nab-paclitaxel.

Kim, ST[Kim, Seung Tae]; Hong, JY[Hong, Jung Yong]; Park, YS[Park, Young Suk]; Kim, SJ[Kim, Seong-Jin]; Park, JO[Park, Joon Oh]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E16299 - E16299PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Tumor microenvironment (TME) dynamics following capecitabine/oxaliplatin (CapeOx) plus pembrolizumab in patients with advanced gastric cancer.

An, M[An, Minae]; Lee, SY[Lee, Song-Yi]; Kim, ST[Kim, Seung Tae]; Kang, WK[Kang, Won Ki]; Lee, J[Lee, Jeeyun]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Structure-based prediction of neoantigens paired with T cell receptors on pre-existing CD8+tumor-infiltrating lymphocytes.

Lee, BR[Lee, Bo Ryeong]; Kim, SS[Kim, Sungsik]; Kim, SM[Kim, Sung-Min]; Park, KC[Park, Keunchil]; Park, WY[Park, Woong-Yang]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Exosome in ascites can be a potential therapeutic target for gastric cancer with malignant ascites.

Hyung, S[Hyung, Sujin]; Ko, J[Ko, Jihoon]; Kim, S[Kim, Seung]; Kang, WK[Kang, Won Ki]; Lee, J[Lee, Jeeyun]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Landscape of tumor mutation burden and correlation to clinical outcomes in 1,744 solid cancers

Jung, J[Jung, Jaeyun]; Park, S[Park, Sehhoon]; Lee, J[Lee, Jeeyun]; Kim, S[Kim, Seung]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Immune landscape of colorectal cancer lung metastasis

Lee, SY[Lee, Song-Yi]; An, M[An, Minae]; Lee, J[Lee, Jeeyun]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E15542 - E15542PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A multicenter phase II randomized trial of durvalumab (D) versus physician's choice chemotherapy (PCC) in patients (pts) with recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3).

Tan, DSP[Tan, David Shao Peng]; Choi, CH[Choi, Chel Hun]; Ngoi, N[Ngoi, Natalie]; Sun, H[Sun, Haoyang]; Heong, V[Heong, Valerie]; Ow, SGW[Ow, Samuel Guan Wei]; Chay, WY[Chay, Wen Yee]; Kim, HS[Kim, Hee Seung]; Lim, YW[Lim, Yi Wan]; Goss, G[Goss, Geraldine], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Adjuvant pembrolizumab for postnephrectomy renal cell carcinoma (RCC): Expanded efficacy analyses from KEYNOTE-564.

Choueiri, TK[Choueiri, Toni K.]; Tomczak, P[Tomczak, Piotr]; Park, SH[Park, Se Hoon]; Venugopal, B[Venugopal, Balaji]; Ferguson, T[Ferguson, Tom]; Symeonides, SN[Symeonides, Stefan N.]; Hajek, J[Hajek, Jaroslav]; Chang, YH[Chang, Yen-Hwa]; Lee, JL[Lee, Jae-Lyun]; Sarwar, N[Sarwar, Naveed], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Treatment patterns and outcomes in resectable early stage NSCLC: Interim analysis of a global real-world study.

Lin, SH[Lin, Steven H.]; Ahn, MJ[Ahn, Myung-Ju]; Nagar, SP[Nagar, Saurabh P.]; Affi, R[Affi, Raafet]; Agulnik, J[Agulnik, Jason]; Shih, JY[Shih, Jin-Yuan]; Hochmair, MJ[Hochmair, Maximilian J.]; Tufman, A[Tufman, Amanda]; Debieuvre, D[Debieuvre, Didier]; Jimenez, M[Jimenez, Maria], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E18803 - E18803PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Association of depth of target lesion response to brigatinib with outcomes in patients with ALK inhibitor-naive ALK plus NSCLC in ALTA-1L.

Camidge, DR[Camidge, D. Ross]; Kim, HR[Kim, Hye Ryun]; Ahn, MJ[Ahn, Myung-Ju]; Yang, JC[Yang, James Chih-Hsin]; Han, JY[Han, Ji-Youn]; Hochmair, M[Hochmair, Maximilian]; Lee, KH[Lee, Ki Hyeong]; Delmonte, A[Delmonte, Angelo]; Campelo, RG[Garcia Campelo, Rosario]; Kim, DW[Kim, Dong-Wan], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Sensitive detection of cancer using deep learning model of cfDNA genome-wide methylation data.

Kim, W[Kim, Wan]; Kim, M[Kim, Minjung]; Park, J[Park, Juntae]; Park, SR[Park, Sook Ryun]; Kim, BH[Kim, Bo Hyun]; Lee, JW[Lee, Jeong-Won]; Oh, D[Oh, Dongryul]; Song, KB[Song, Ki Byung]; Jun, E[Jun, Eunsung]; Shim, JH[Shim, Ju Hyun], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E18789 - E18789PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
A single-arm, phase II study of niraparib and bevacizumab maintenance therapy in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor: Korean Gynecologic Oncology Group (KGOG 3056)/NIRVANA-R trial.

Lee, JY[Lee, Jung-Yun]; Park, J[Park, Junsik]; Lee, JK[Lee, Jae Kwan]; Jeong, DH[Jeong, Dae Hoon]; Kim, SI[Kim, Se Ik]; Choi, MC[Choi, Min Chul]; Kim, BG[Kim, Byoung-Gie]; Lim, MC[Lim, Myong Cheol]; Park, JY[Park, Jeong-Yeol]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
High atezolizumab antidrug antibody levels are associated with unfavorable clinical outcomes and diminished T cell responses following atezolizumab and bevacizumab treatment in advanced hepatocellular carcinoma.

Chon, HJ[Chon, Hong Jae]; Kim, C[Kim, Chan]; Yang, H[Yang, Hannah]; Kim, I[Kim, Ilhwan]; Kang, BD[Kang, Beodeul]; Kim, HY[Kim, Hyeyeong]; Kim, HH[Kim, Hyunho]; Lee, WS[Lee, Won Suk]; Jung, SH[Jung, Sanghoon]; Lim, HY[Lim, Ho Yeong], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
First-line lenvatinib plus pembrolizumab plus chemotherapy in esophageal squamous cell carcinoma: LEAP-014 trial in progress

Sun, JM[Sun, Jong-Mu]; Enzinger, PC[Enzinger, Peter C.]; Adenis, A[Adenis, Antoine]; Shah, MA[Shah, Manish A.]; Kato, K[Kato, Ken]; Bennouna, J[Bennouna, Jaafar]; Doi, T[Doi, Toshihiko]; Hawk, NN[Hawk, Natalyn Nicole]; Yu, L[Yu, Li]; Shah, S[Shah, Sukrut], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.

Kwon, M[Kwon, Minsuk]; Kim, ST[Kim, Seung Tae]; Hong, JY[Hong, Jung Yong]; Kim, G[Kim, Gahyun]; Smith, S[Smith, Simon]; Mortimer, PG[Mortimer, Peter G.]; LoembE, B[LoembE, Bienvenu]; Dean, E[Dean, Emma]; Kang, WK[Kang, Won Ki]; Lee, J[Lee, Jeeyun]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Prevalence of MET aberration using next generation sequencing in oncology clinic: A real-world experience.

Ko, J[Ko, Jihoon]; Jung, J[Jung, Jaeyun]; Kim, KM[Kim, Kyoung-Mee]; Kim, ST[Kim, Seung Tae]; Kang, W[Kang, Wonki]; Lee, J[Lee, Jeeyun]

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16, pp.E16099 - E16099PublisherLIPPINCOTT WILLIAMS & WILKINS
1 2 3 4 5 6 7 8 9 10 last
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어